Variables | OS | ||
---|---|---|---|
p | Hazard Ratio | 95% confidence interval | |
Univariate analysis | |||
 Age (<  60 vs. ≥ 60) | 0.238 | 1.422 | 0.792–2.554 |
 Gender (Male vs. Female) | 0.374 | 1.274 | 0.746–2.177 |
 Pathological stage (I-II vs. III) | < 0.001 | 2.964 | 1.671–5.259 |
 tumor size (<  5 cm vs. ≥ 5 cm) | 0.086 | 1.605 | 0.935–2.755 |
 T classification (T2-T3 vs. T4) | 0.207 | 1.539 | 0.788–3.007 |
 N classification (N0 vs. N1-N2) | < 0.001 | 2.912 | 1.668–5.082 |
 M classification (absent vs present) | 0.099 | 2.380 | 0.850–6.667 |
 Clinical stage (I-II vs III-IV) | < 0.001 | 3.060 | 1.720–5.442 |
 HSP90 | < 0.001 | 6.869 | 2.725–17.317 |
 PUS7 | < 0.001 | 3.470 | 1.876–6.419 |
 LASP1 | < 0.001 | 6.974 | 3.133–15.527 |
Multivariate analysis | |||
 Pathological stage (I-II vs. III) | < 0.001 | 3.867 | 1.870–7.996 |
 N classification (N0 vs. N1-N2) | 0.063 | 0.706 | 0.162–3.080 |
 Clinical stage (I-II vs III-IV) | 0.734 | 3.117 | 0.682–14.243 |
 HSP90 (high vs. low) | 0.336 | 1.959 | 0.579–6.628 |
 PUS7 (high vs. low) | 0.003 | 3.304 | 1.535–7.108 |
 LASP1 (high vs. low) | 0.019 | 2.923 | 1.136–7.515 |